Flex Pharma, Inc. is a clinical-stage biotechnology company founded by the National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Christoph Westphal, M.D., Ph.D. At Flex Pharma are developing innovative and proprietary treatments to specifically treat cramping and spasticity associated with neurological disorders.
Technology: Health Care, Life Science, Medical, Medical Device, Pharmaceutical
Headquarters: Boston, Massachusetts, United States
Founded Date: 2014
Employees Number: 11-50
Funding Status: IPO
Register and Claim Ownership